The role of serum TSH in the initiation and propagation of TAO is well documented after RAI therapy [13–16], and empirical thyroid hormone replacement after RAI ablation, but before the onset of biochemical hypothyroidism, has been shown to reduce the incidence of TAO after RAI [17]. The gene discussed is TG; the disease is thromboangiitis obliterans.